Literature DB >> 33452116

Socioeconomic status and cardiovascular health in the COVID-19 pandemic.

Jeremy Naylor-Wardle1, Ben Rowland1, Vijay Kunadian2,3.   

Abstract

The goals of this review are to evaluate the impact of socioeconomic (SE) status on the general health and cardiovascular health of individuals during the COVID-19 pandemic and also discuss the measures to address disparity. SE status is a strong predictor of premature morbidity and mortality within general health. A lower SE status also has implications of increased cardiovascular disease (CVD) mortality and poorer CVD risk factor profiles. CVD comorbidity is associated with a higher case severity and mortality rate from COVID-19, with both CVD and COVID-19 sharing important risk factors. The COVID-19 pandemic has adversely affected people of a lower SE status and of ethnic minority group, who in the most deprived regions are suffering double the mortality rate of the least deprived. The acute stress, economic recession and quarantine restrictions in the wake of COVID-19 are also predicted to cause a decline in mental health. This could pose substantial increase to CVD incidence, particularly with acute pathologies such as stroke, acute coronary syndrome and cardiogenic shock among lower SE status individuals and vulnerable elderly populations. Efforts to tackle SE status and CVD may aid in reducing avoidable deaths. The implementation of 'upstream' interventions and policies demonstrates promise in achieving the greatest population impact, aiming to protect and empower individuals. Specific measures may involve risk factor targeting restrictions on the availability and advertisement of tobacco, alcohol and high-fat and salt content food, and targeting SE disparity with healthy and secure workplaces. © Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  acute coronary syndrome; atherosclerosis; quality of health care; risk factors

Year:  2021        PMID: 33452116     DOI: 10.1136/heartjnl-2020-318425

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  5 in total

1.  COVID-19 and health in children and adolescents in the US: A narrative systematic review.

Authors:  Selicia T Mayra; Jayanthi Kandiah; Constance E McIntosh
Journal:  Psychol Sch       Date:  2022-04-29

2.  Opaganib in Coronavirus Disease 2019 Pneumonia: Results of a Randomized, Placebo-Controlled Phase 2a Trial.

Authors:  Kevin L Winthrop; Alan W Skolnick; Adnan M Rafiq; Scott H Beegle; Julian Suszanski; Guenther Koehne; Ofra Barnett-Griness; Aida Bibliowicz; Reza Fathi; Patricia Anderson; Gilead Raday; Gina Eagle; Vered Katz Ben-Yair; Harold S Minkowitz; Mark L Levitt; Michael S Gordon
Journal:  Open Forum Infect Dis       Date:  2022-05-11       Impact factor: 4.423

3.  Convicted drinking and driving offenders: Comparing alcohol use before and after the pandemic outbreak.

Authors:  Amy R Manning; Eduardo Romano; Josal Diebold; Thomas H Nochajski; Eileen Taylor; Robert B Voas; Michael Scherer
Journal:  Alcohol Clin Exp Res       Date:  2021-04-30       Impact factor: 3.928

4.  Gender and Social Inequalities in Awareness of Coronary Artery Disease in European Countries.

Authors:  Antonio Daponte-Codina; Emily C Knox; Inmaculada Mateo-Rodriguez; Amanda Seims; Vera Regitz-Zagrosek; Angela H E M Maas; Alan White; Floris Barnhoorn; Fernando Rosell-Ortiz
Journal:  Int J Environ Res Public Health       Date:  2022-01-26       Impact factor: 3.390

5.  Inequitable impact of infection: social gradients in severe COVID-19 outcomes among all confirmed SARS-CoV-2 cases during the first pandemic wave in Sweden.

Authors:  Per E Gustafsson; Miguel San Sebastian; Osvaldo Fonseca-Rodriguez; Anne-Marie Fors Connolly
Journal:  J Epidemiol Community Health       Date:  2021-09-15       Impact factor: 3.710

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.